(IN BRIEF) Researchers at the Karlsruhe Institute of Technology (KIT) have created a nanodroplet-based chip platform that combines drug synthesis, biological testing, and chemical analysis in a single workflow. Each droplet measures only 200 nanoliters and contains 300 cells, enabling … Read the full press release →
Posted in Business, Education, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged Angewandte Chemie, biotechnology, cancer research, Carsten Hopf, CeMOS, colon cancer, direct-to-biology, drug discovery, HT-29, Karlsruhe Institute of Technology, KIT, Liana Bauer, MALDI-MSI, MEK inhibitors, miniaturized workflow, mirdametinib, nanodroplet array platform, Pavel Levkin, pharmaceuticals, skin cancer, TH Mannheim